Northwire Canada EditionTuesday, July 14, 2026
Northwire
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Earnings

Eshbal Functional loses $507,000 (U.S.) in Q3

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. reported consolidated financial results for the three and nine months ended September 30, 2025, highlighting strong revenue growth and margin expansion in its core Israeli operations.
  • The company reported a net loss of $2.1 million for the nine-month period, primarily driven by a $2 million non-cash, non-recurring listing expense associated with its recent Reverse Takeover (RTO).
  • Management provided a corporate update on its North American expansion strategy, including a definitive agreement to acquire a majority interest in D2BD Foods and plans for local manufacturing to commence in Q1 2026.

Key Details

  • Q3 2025 Revenue: $3.38 million, representing a 25% increase from $2.7 million in Q3 2024.
  • Q3 2025 Gross Profit: $995,000 (29% of revenue), up from $596,000 (22% of revenue) in Q3 2024.
  • Nine-Month 2025 Revenue: $10.1 million, a 16% increase from $8.7 million in the prior-year period.
  • Nine-Month 2025 Gross Profit: $2.7 million (27% of revenue), up from $2 million (22.8% of revenue) in the prior-year period.
  • Nine-Month 2025 EBITDA: $679,000.
  • Nine-Month 2025 Operating Income: $127,000.
  • Nine-Month 2025 Net Loss: $2.1 million, significantly impacted by a $2 million non-recurring non-cash listing expense from the RTO.
  • Q3 2025 Net Loss: $507,000.
  • Eshbal Israel (Subsidiary) Performance:
    • Revenues in New Israeli Shekels increased by approximately 10% year-over-year.
    • Gross margin expanded to 25%.
    • Net profit rose by more than 50% in local-currency terms to approximately 6% of revenue.
  • North American Expansion Updates:
    • Signed a definitive agreement to acquire a majority interest in D2BD Foods (New York) to gain initial distribution access in key U.S. retail channels.
    • Strengthened commercial presence with senior leadership and dedicated broker relationships for gluten-free pita bread and other products.
    • Local manufacturing preparation is underway, expected to commence in Q1 2026 to support scale, logistics, and cost-efficiency.

Notable Quotes

  • Tomer Bar Meir, CEO: "Q3 reinforces the strength of our core Israeli operation: Revenue is growing, production is more efficient and margins continue to improve. These results reflect real demand and operational efficiency and discipline."
  • Tomer Bar Meir, CEO: "While consolidated results are influenced by currency fluctuations and listing-related accounting and one-time items, our underlying fundamentals remain strong. We are focused on expanding our North American footprint, enhancing operational efficiency and executing our M&A-driven growth strategy."
Read the original news release →

More from Eshbal Functional Food Inc